PUBLICATIONS · 20843246
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2010 Sep 16
- First author
- Verstovsek S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2010 Sep 16;363(12):1180-2. doi: 10.1056/NEJMe1005856.
- note
- Source null
- related pmid
- 20843255
- relationship
- Comment in
- citation
- N Engl J Med. 2010 Dec 16;363(25):2464; author reply 2464-5; discussion 2465. doi: 10.1056/NEJMc1011635.
- note
- Source null
- related pmid
- 21158663
- relationship
- Comment in
Authors and identifiers
- name
- Verstovsek S
- type
- Author
- name
- Kantarjian H
- type
- Author
- name
- Mesa RA
- type
- Author
- name
- Pardanani AD
- type
- Author
- name
- Cortes-Franco J
- type
- Author
- name
- Thomas DA
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Fridman JS
- type
- Author
- name
- Bradley EC
- type
- Author
- name
- Erickson-Viitanen S
- type
- Author
- name
- Vaddi K
- type
- Author
- name
- Levy R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Verstovsek S
- type
- Author
- name
- Kantarjian H
- type
- Author
- name
- Mesa RA
- type
- Author
- name
- Pardanani AD
- type
- Author
- name
- Cortes-Franco J
- type
- Author
- name
- Thomas DA
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Fridman JS
- type
- Author
- name
- Bradley EC
- type
- Author
- name
- Erickson-Viitanen S
- type
- Author
- name
- Vaddi K
- type
- Author
- name
- Levy R
- type
- Author
- bibliography ids
- nci-bib-3ca8ec065cf17be5d6f850d2
- book metadata
- content sha256
- 246296801aa626ac88ce4bcde30a168b91117fb89e17c1da28f3c7f53269842d
- document type
- citation
- dois
- 10.1056/NEJMoa1002028
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20843246
- immutable id
- pubmed:20843246@246296801aa626ac88ce4bcde30a168b91117fb89e17c1da28f3c7f53269842d
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 12
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 1117-27
- volume
- 363
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2010 Sep 16;363(12):1180-2. doi: 10.1056/NEJMe1005856.
- note
- Source null
- related pmid
- 20843255
- relationship
- Comment in
- citation
- N Engl J Med. 2010 Dec 16;363(25):2464; author reply 2464-5; discussion 2465. doi: 10.1056/NEJMc1011635.
- note
- Source null
- related pmid
- 21158663
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 20843246
- provenance
- batch id
- 10a38257e12e9ed1867a
- provider
- NCBI PubMed ESummary
- record sha256
- 92a587a9d5770d05ba9fb3177760218d8325fe1c1d8c737ff73107cc1f5aaaf6
- response sha256
- 84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
- retrieved at
- 2026-09-09T23:46:35.793530+00:00
- publication date
- display
- 2010 Sep 16
- precision
- day
- year
- 2010
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.
Preserved source evidence · Not medical advice
Triangle